id	sid	eid	entity	type
faba-238	1	1	217	CARDINAL
faba-238	1	2	6	CARDINAL
faba-238	1	3	2	CARDINAL
faba-238	1	4	2024	CARDINAL
faba-238	1	5	issn 2603-5324	PERSON
faba-238	1	6	stoyan stoyanov department of finance	ORG
faba-238	1	7	university of national and world economy, sofia	ORG
faba-238	1	8	bulgaria	GPE
faba-238	1	9	15	CARDINAL
faba-238	1	10	october 2024	DATE
faba-238	1	11	23	CARDINAL
faba-238	1	12	november 2024	DATE
faba-238	1	13	10	CARDINAL
faba-238	1	14	2024	CARDINAL
faba-238	7	1	three	CARDINAL
faba-238	9	1	three	CARDINAL
faba-238	15	1	jel	ORG
faba-238	16	1	6	CARDINAL
faba-238	16	2	2	CARDINAL
faba-238	16	3	2024	CARDINAL
faba-238	16	4	218	CARDINAL
faba-238	18	1	one	CARDINAL
faba-238	21	1	two	CARDINAL
faba-238	22	1	two	CARDINAL
faba-238	22	2	1	CARDINAL
faba-238	23	1	2	CARDINAL
faba-238	24	1	daily	DATE
faba-238	33	1	2023	CARDINAL
faba-238	34	1	2023	CARDINAL
faba-238	35	1	2023	CARDINAL
faba-238	37	1	kumar et al	PERSON
faba-238	37	2	2019	DATE
faba-238	39	1	2024	CARDINAL
faba-238	43	1	nenkov	ORG
faba-238	43	2	hristozov 2023	ORG
faba-238	46	1	damodaran	PERSON
faba-238	46	2	2002	DATE
faba-238	47	1	koller et al	PERSON
faba-238	48	1	2015	CARDINAL
faba-238	49	1	third	ORDINAL
faba-238	49	2	miciuła et al	FAC
faba-238	49	3	2020	DATE
faba-238	51	1	nenkov	ORG
faba-238	51	2	hristozov 2022	ORG
faba-238	52	1	one	CARDINAL
faba-238	52	2	dcf valuation models	ORG
faba-238	52	3	hristozov 2023	ORG
faba-238	53	1	6	CARDINAL
faba-238	53	2	2	CARDINAL
faba-238	53	3	2024 219	DATE
faba-238	54	1	2014	DATE
faba-238	55	1	2006	DATE
faba-238	57	1	nenkov	PERSON
faba-238	57	2	2015	CARDINAL
faba-238	58	1	2023	CARDINAL
faba-238	61	1	harvard university	ORG
faba-238	63	1	al	PERSON
faba-238	63	2	2022	CARDINAL
faba-238	65	1	2023	CARDINAL
faba-238	65	2	germany	GPE
faba-238	68	1	two	CARDINAL
faba-238	68	2		CARDINAL
faba-238	68	3	2023	CARDINAL
faba-238	68	4		CARDINAL
faba-238	69	1	2023	CARDINAL
faba-238	74	1	50	CARDINAL
faba-238	74	2	1	CARDINAL
faba-238	76	1	bulgarian	NORP
faba-238	76	2	nenkov	ORG
faba-238	76	3	2023	CARDINAL
faba-238	76	4	bulgarian	NORP
faba-238	77	1	bulgaria	GPE
faba-238	78	1	hungarian	NORP
faba-238	79	1	three	CARDINAL
faba-238	80	1	5	CARDINAL
faba-238	81	1	3	CARDINAL
faba-238	82	1	2014	DATE
faba-238	83	1	2023	CARDINAL
faba-238	84	1	31.12.2023	DATE
faba-238	84	2	fiscal year	DATE
faba-238	85	1	1	CARDINAL
faba-238	87	1	stoyan stoyanov/ finance	ORG
faba-238	87	2	6	CARDINAL
faba-238	87	3	2	CARDINAL
faba-238	87	4	2024 220 2	DATE
faba-238	88	1	a.	PERSON
faba-238	94	1	up to 5	CARDINAL
faba-238	95	1	ev/ebitda	ORG
faba-238	96	1	31.12.2023	CARDINAL
faba-238	98	1	3	CARDINAL
faba-238	99	1	five	CARDINAL
faba-238	100	1		CARDINAL
faba-238	101	1		CARDINAL
faba-238	102	1		CARDINAL
faba-238	104	1		CARDINAL
faba-238	104	2	3	CARDINAL
faba-238	105	1	three	CARDINAL
faba-238	107	1		CARDINAL
faba-238	114	1	46 seconds	TIME
faba-238	117	1	2	CARDINAL
faba-238	118	1	1 minute and 26 seconds	TIME
faba-238	119	1	at least 30	CARDINAL
faba-238	119	2	at least 5000	CARDINAL
faba-238	121	1	5	CARDINAL
faba-238	121	2	first	ORDINAL
faba-238	121	3	5	CARDINAL
faba-238	121	4	roche	ORG
faba-238	121	5	merck & co.	ORG
faba-238	121	6	gsk plc	ORG
faba-238	121	7	johnson	PERSON
faba-238	121	8	johnson	PERSON
faba-238	121	9	teva pharmaceutical industries limited	ORG
faba-238	121	10	appendix 1	LAW
faba-238	123	1	23 min	QUANTITY
faba-238	123	2	sec	ORG
faba-238	123	3	yahoo	ORG
faba-238	123	4	2024	CARDINAL
faba-238	125	1	6	CARDINAL
faba-238	125	2	2	CARDINAL
faba-238	125	3	2024 221	DATE
faba-238	127	1	1	CARDINAL
faba-238	127	2	1	CARDINAL
faba-238	127	3	first	ORDINAL
faba-238	127	4	14.10	CARDINAL
faba-238	127	5	9.80 4.39	CARDINAL
faba-238	127	6	32.72	CARDINAL
faba-238	127	7	54.22	CARDINAL
faba-238	127	8	40%	PERCENT
faba-238	127	9	40%	PERCENT
faba-238	127	10	20%	PERCENT
faba-238	127	11	37.41	CARDINAL
faba-238	127	12	37.41	MONEY
faba-238	128	1	25 minutes and 48 seconds	TIME
faba-238	128	2	appendix 2	LAW
faba-238	129	1	1 minute and 15 seconds	TIME
faba-238	131	1	5	CARDINAL
faba-238	132	1	teva pharmaceutical industries limited	ORG
faba-238	132	2	hikma pharmaceuticals plc	ORG
faba-238	132	3	sanofi s.a.	ORG
faba-238	132	4	bayer ag	ORG
faba-238	132	5	novartis ag	ORG
faba-238	132	6	appendix 2	PRODUCT
faba-238	133	1	25 seconds	TIME
faba-238	139	1	12 minutes and 9 seconds	TIME
faba-238	144	1	2	CARDINAL
faba-238	144	2	2	CARDINAL
faba-238	144	3	second	ORDINAL
faba-238	144	4	11.60	CARDINAL
faba-238	144	5	8.10 2.33	CARDINAL
faba-238	144	6	26.92	CARDINAL
faba-238	144	7	29.21	MONEY
faba-238	144	8	40%	PERCENT
faba-238	144	9	40%	PERCENT
faba-238	144	10	20%	PERCENT
faba-238	144	11	27.82	CARDINAL
faba-238	144	12	27.82	MONEY
faba-238	145	1	13 minutes and 49 seconds	TIME
faba-238	145	2	appendix 3	LAW
faba-238	147	1	one	CARDINAL
faba-238	149	1	innoviva, inc	ORG
faba-238	149	2	faes farma	ORG
faba-238	149	3	s.a.	GPE
faba-238	149	4	virbac sa	ORG
faba-238	149	5	bavarian nordic	ORG
faba-238	150	1	48 min and	DATE
faba-238	150	2	sec	ORG
faba-238	151	1	yahoo	ORG
faba-238	151	2	2024	CARDINAL
faba-238	151	3	gfo	PERSON
faba-238	152	1	6	CARDINAL
faba-238	152	2	2	CARDINAL
faba-238	152	3	2024	CARDINAL
faba-238	152	4	222	CARDINAL
faba-238	152	5	22 min	QUANTITY
faba-238	152	6	sec	ORG
faba-238	157	1	3	CARDINAL
faba-238	157	2	3	CARDINAL
faba-238	157	3	third	ORDINAL
faba-238	157	4	14.05	CARDINAL
faba-238	157	5	6.25 2.12	CARDINAL
faba-238	157	6	32.60	CARDINAL
faba-238	157	7	26.62	CARDINAL
faba-238	157	8	40%	PERCENT
faba-238	157	9	40%	PERCENT
faba-238	157	10	20%	PERCENT
faba-238	157	11	27.10	CARDINAL
faba-238	157	12	27.1	MONEY
faba-238	158	1	70 minutes and 56 seconds	TIME
faba-238	158	2	appendix 4	LAW
faba-238	159	1	three	CARDINAL
faba-238	160	1	second	ORDINAL
faba-238	162	1	first	ORDINAL
faba-238	163	1	third	ORDINAL
faba-238	164	1	first	ORDINAL
faba-238	166	1	hikma pharmaceuticals plc	ORG
faba-238	166	2	26.47	CARDINAL
faba-238	168	1	first	ORDINAL
faba-238	170	1	second	ORDINAL
faba-238	172	1	third	ORDINAL
faba-238	172	2	almost five	CARDINAL
faba-238	172	3	appendix 5	LAW
faba-238	173	1	31.12.2023	CARDINAL
faba-238	173	2	25.2	MONEY
faba-238	174	1	first	ORDINAL
faba-238	175	1	second	ORDINAL
faba-238	176	1	third	ORDINAL
faba-238	178	1	first	ORDINAL
faba-238	180	1	second	ORDINAL
faba-238	180	2	3rd	ORDINAL
faba-238	181	1	3rd	ORDINAL
faba-238	182	1	6	CARDINAL
faba-238	182	2	2	CARDINAL
faba-238	182	3	2024 223	DATE
faba-238	183	1	one	CARDINAL
faba-238	186	1	seconds	TIME
faba-238	193	1	second	ORDINAL
faba-238	194	1	2nd	ORDINAL
faba-238	195	1	first	ORDINAL
faba-238	202	1	aleksandrova a.	PERSON
faba-238	202	2	z. zhelev	PERSON
faba-238	203	1	2023	CARDINAL
faba-238	205	1	6-8	DATE
faba-238	206	1	https://doi.org/10.3390/risks11050091	NORP
faba-238	207	1	y.q.	GPE
faba-238	207	2	a. chia	PERSON
faba-238	207	3	s. saghafian	PERSON
faba-238	208	1	2022	CARDINAL
faba-238	210	1	11	CARDINAL
faba-238	210	2	271-294	CARDINAL
faba-238	210	3	annual	DATE
faba-238	211	1	2023	CARDINAL
faba-238	212	1	bahoo	ORG
faba-238	212	2	s.	PERSON
faba-238	212	3	m. cucculelli	PERSON
faba-238	212	4	x. goga	GPE
faba-238	212	5	j. mondolo	PERSON
faba-238	213	1	2024	DATE
faba-238	215	1	sn	ORG
faba-238	215	2	4	CARDINAL
faba-238	215	3	3-5	TIME
faba-238	216	1	2014	DATE
faba-238	217	1	european	NORP
faba-238	218	1	columbia business school	ORG
faba-238	218	2	26(4	CARDINAL
faba-238	218	3	106	CARDINAL
faba-238	218	4	bonaparte	PERSON
faba-238	218	5	2023	CARDINAL
faba-238	220	1	university of colorado	ORG
faba-238	220	2	denver	GPE
faba-238	223	1	2023	CARDINAL
faba-238	226	1	2017	CARDINAL
faba-238	228	1	june 2024	DATE
faba-238	229	1	damodaran	PERSON
faba-238	230	1	damodaran	PERSON
faba-238	231	1	john wiley & sons	ORG
faba-238	231	2	35	CARDINAL
faba-238	232	1	fernandez	PERSON
faba-238	232	2	2023	CARDINAL
faba-238	235	1	iese business school, university of navarra http://dx.doi.org/10.2139/ssrn.274972	ORG
faba-238	235	2	hoang	PERSON
faba-238	235	3	d.	NORP
faba-238	235	4	k. wiegratz	PERSON
faba-238	236	1	2023	CARDINAL
faba-238	237	1	european financial management	ORG
faba-238	237	2	29	CARDINAL
faba-238	237	3	1657-1701	CARDINAL
faba-238	240	1	2023	CARDINAL
faba-238	242	1	london	GPE
faba-238	242	2	ivs council	ORG
faba-238	243	1	978	CARDINAL
faba-238	243	2	0	CARDINAL
faba-238	243	3	n.	PERSON
faba-238	243	4	j. d. srivastava	PERSON
faba-238	243	5	h. bisht	PERSON
faba-238	244	1	2019	DATE
faba-238	246	1	https://doi.org/10.3390/risks11050091	NORP
faba-238	246	2	https://corporatefinanceinstitute.com/resources/valuation/private-company-valuation/ http://dx.doi.org/10.2139/ssrn.274972	PERSON
faba-238	246	3	6	CARDINAL
faba-238	246	4	2	CARDINAL
faba-238	246	5	2024	CARDINAL
faba-238	246	6	224	CARDINAL
faba-238	246	7	gujarat research society	ORG
faba-238	246	8	21	CARDINAL
faba-238	246	9	79	CARDINAL
faba-238	247	1	koller	ORG
faba-238	247	2	t., m. goedhart	PERSON
faba-238	247	3	d. wessels	PERSON
faba-238	247	4	mckinsey & company	ORG
faba-238	248	1	2015	CARDINAL
faba-238	250	1	john wiley &sons	ORG
faba-238	250	2	m. kadłubek	PERSON
faba-238	250	3	2020	DATE
faba-238	253	1	2699	CARDINAL
faba-238	253	2	1-4	DATE
faba-238	253	3	nenkov	PERSON
faba-238	253	4	2015	CARDINAL
faba-238	255	1	university of national and world	ORG
faba-238	256	1	978	CARDINAL
faba-238	256	2	181	CARDINAL
faba-238	256	3	d.	NORP
faba-238	256	4	y. hristozov	PERSON
faba-238	257	1	2023	CARDINAL
faba-238	260	1	32	CARDINAL
faba-238	260	2	114	CARDINAL
faba-238	260	3	nenkov	PERSON
faba-238	260	4	d.	NORP
faba-238	260	5	y. hristozov	ORG
faba-238	261	1	2022	CARDINAL
faba-238	262	1	dcf valuation	ORG
faba-238	263	1	4	CARDINAL
faba-238	263	2	626	CARDINAL
faba-238	264	1	10.37075	CARDINAL
faba-238	264	2	nenkov	PERSON
faba-238	264	3	d. 2023	PERSON
faba-238	265	1	bulgaria	GPE
faba-238	266	1	5(1):1-13	DATE
faba-238	268	1	openai	PERSON
faba-238	268	2	j. achiam	PERSON
faba-238	268	3	s. adler	PERSON
faba-238	269	1	al	PERSON
faba-238	269	2	2023	CARDINAL
faba-238	270	1	gpt-4	PERSON
faba-238	272	1	https://doi.org/10.48550/arxiv.2303.08774	ORG
faba-238	272	2	peer group financial data	ORG
faba-238	273	1	appendix 1	PERSON
faba-238	273	2	4	CARDINAL
faba-238	273	3	peer group	ORG
faba-238	273	4	97413	CARDINAL
faba-238	273	5	1896	DATE
faba-238	273	6	gsk https://www.gsk.com/en-gb/ pharmaceutical manufacturing	ORG
faba-238	273	7	106892 1830	DATE
faba-238	273	8	merck & co.	ORG
faba-238	274	1	johnson	PERSON
faba-238	274	2	johnson	PERSON
faba-238	274	3	5	CARDINAL
faba-238	274	4	teva pharmaceutical industries	ORG
faba-238	274	5	24909	DATE
faba-238	274	6	1901	DATE
faba-238	274	7	www.comparables.ai	GPE
faba-238	274	8	gpt 4.0	PRODUCT
faba-238	274	9	5	CARDINAL
faba-238	274	10	peer group	ORG
faba-238	274	11	$	MONEY
faba-238	274	12	$	MONEY
faba-238	274	13	$	MONEY
faba-238	274	14	$	MONEY
faba-238	274	15	$	MONEY
faba-238	274	16	million	CARDINAL
faba-238	274	17	teva pharmaceutical industries	ORG
faba-238	274	18	14.93	CARDINAL
faba-238	274	19	1158	CARDINAL
faba-238	274	20	hikma pharmaceutical plc	ORG
faba-238	274	21	2.88	CARDINAL
faba-238	274	22	0.19	CARDINAL
faba-238	274	23	4.4	CARDINAL
faba-238	274	24	221	CARDINAL
faba-238	274	25	sanofi s.a.	ORG
faba-238	275	1	45.37	CARDINAL
faba-238	275	2	2516	CARDINAL
faba-238	275	3	bayer ag	ORG
faba-238	275	4	53.42	CARDINAL
faba-238	275	5	novartis	ORG
faba-238	275	6	52.73	CARDINAL
faba-238	275	7	16.16	MONEY
faba-238	275	8	11.73	CARDINAL
faba-238	275	9	https://doi.org/10.48550/arxiv.2303.08774	ORG
faba-238	275	10	6	CARDINAL
faba-238	275	11	2	CARDINAL
faba-238	275	12	2024 225	DATE
faba-238	275	13	6	CARDINAL
faba-238	275	14	10.9	CARDINAL
faba-238	275	15	9.88 2.33	CARDINAL
faba-238	275	16	hikma pharmaceuticals plc	ORG
faba-238	275	17	14.3	CARDINAL
faba-238	275	18	7.8 1.84	CARDINAL
faba-238	275	19	sanofi s.a.	ORG
faba-238	275	20	11.6 8.1 2.34	CARDINAL
faba-238	275	21	bayer ag	ORG
faba-238	275	22	9.8 7.8 1.71	QUANTITY
faba-238	275	23	13.2	CARDINAL
faba-238	275	24	12.6 4.32	CARDINAL
faba-238	275	25	appendix 2	PRODUCT
faba-238	275	26	first	ORDINAL
faba-238	275	27	7	CARDINAL
faba-238	275	28	first	ORDINAL
faba-238	276	1	10.93 7.74 2.13	CARDINAL
faba-238	276	2	roche	ORG
faba-238	276	3	17.47	CARDINAL
faba-238	276	4	3.68	MONEY
faba-238	276	5	9.83 7.61 2.47	MONEY
faba-238	276	6	merck & co., inc	ORG
faba-238	276	7	60.57	CARDINAL
faba-238	276	8	johnson	PERSON
faba-238	276	9	johnson	PERSON
faba-238	276	10	7.34 15.56	CARDINAL
faba-238	276	11	teva pharmaceutical industries limited	ORG
faba-238	276	12	24.65	CARDINAL
faba-238	276	13	6.70	MONEY
faba-238	276	14	14.10	CARDINAL
faba-238	276	15	4.39	CARDINAL
faba-238	276	16	www.comparables.ai	GPE
faba-238	276	17	8	CARDINAL
faba-238	277	1	first	ORDINAL
faba-238	278	1	5 893 000 000 6 076 000 000 9 877 500 000	QUANTITY
faba-238	278	2	150 000 000 150 000 000 150 000 000	QUANTITY
faba-238	278	3	320 000 000 320 000 000 320 000 000	MONEY
faba-238	278	4	6 063 000 000 6 246 000 000 10 047 500 000	QUANTITY
faba-238	278	5	185 310 000 185 310 000 185 310 000	QUANTITY
faba-238	278	6	32.72	CARDINAL
faba-238	278	7	54.22	CARDINAL
faba-238	278	8	40%	PERCENT
faba-238	278	9	40%	PERCENT
faba-238	278	10	20%	PERCENT
faba-238	278	11	13.09	CARDINAL
faba-238	278	12	13.48 10.84	CARDINAL
faba-238	278	13	37.41	CARDINAL
faba-238	278	14	3	CARDINAL
faba-238	279	1	second	ORDINAL
faba-238	279	2	9	CARDINAL
faba-238	279	3	second	ORDINAL
faba-238	281	1	10.93 7.74 2.13	CARDINAL
faba-238	281	2	teva pharmaceutical industries	ORG
faba-238	281	3	10.90	CARDINAL
faba-238	281	4	9.88 2.33	CARDINAL
faba-238	281	5	hikma pharmaceuticals plc	ORG
faba-238	281	6	14.30	CARDINAL
faba-238	281	7	7.80 1.84	CARDINAL
faba-238	281	8	sanofi s.a.	ORG
faba-238	281	9	11.60	CARDINAL
faba-238	281	10	8.10 2.34	QUANTITY
faba-238	281	11	bayer ag	ORG
faba-238	281	12	9.80	CARDINAL
faba-238	281	13	8.80 1.71	QUANTITY
faba-238	281	14	novartis ag	ORG
faba-238	281	15	13.20	CARDINAL
faba-238	281	16	11.96 9.24 2.51	MONEY
faba-238	281	17	11.60	CARDINAL
faba-238	281	18	2.33	CARDINAL
faba-238	281	19	www.comparables.ai	GPE
faba-238	281	20	6	CARDINAL
faba-238	281	21	2	CARDINAL
faba-238	281	22	2024 226	DATE
faba-238	281	23	10	CARDINAL
faba-238	282	1	second	ORDINAL
faba-238	282	2	4 818 000 000 5 022 000 000 5 242 500 000	QUANTITY
faba-238	282	3	150 000 000 150 000 000 150 000 000	QUANTITY
faba-238	282	4	320 000 000 320 000 000 320 000 000	MONEY
faba-238	282	5	4 988 000 000 5 192 000 000 5 412 500 000	QUANTITY
faba-238	282	6	185 310 000 185 310 000 185 310 000	QUANTITY
faba-238	282	7	26.92	CARDINAL
faba-238	282	8	29.21	MONEY
faba-238	282	9	40%	PERCENT
faba-238	282	10	40%	PERCENT
faba-238	282	11	20%	PERCENT
faba-238	282	12	10.77	CARDINAL
faba-238	282	13	27.82	CARDINAL
faba-238	282	14	appendix 4	PRODUCT
faba-238	283	1	third	ORDINAL
faba-238	283	2	11	CARDINAL
faba-238	284	1	third	ORDINAL
faba-238	285	1	10.93 7.74 2.13	CARDINAL
faba-238	285	2	innoviva, inc	ORG
faba-238	285	3	5.73	CARDINAL
faba-238	285	4	10.86 7.79 2.12	CARDINAL
faba-238	285	5	17.30	CARDINAL
faba-238	285	6	bavarian nordic	ORG
faba-238	285	7	14.05	CARDINAL
faba-238	285	8	ipsen s.a.	ORG
faba-238	285	9	15.05	CARDINAL
faba-238	285	10	2.87	CARDINAL
faba-238	285	11	12.60 7.21 2.50	MONEY
faba-238	285	12	14.05	CARDINAL
faba-238	285	13	2.12	CARDINAL
faba-238	285	14	12	CARDINAL
faba-238	285	15	third	ORDINAL
faba-238	286	1	5 871	CARDINAL
faba-238	286	2	875	CARDINAL
faba-238	286	3	150 000 000 150 000 000 150 000 000	QUANTITY
faba-238	286	4	320 000 000 320 000 000 320 000 000	MONEY
faba-238	286	5	6 041 325	CARDINAL
faba-238	286	6	185 310 000 185 310 000 185 310 000	QUANTITY
faba-238	286	7	32.60	CARDINAL
faba-238	286	8	26.62	CARDINAL
faba-238	286	9	40%	PERCENT
faba-238	286	10	40%	PERCENT
faba-238	286	11	20%	PERCENT
faba-238	286	12	13.04	CARDINAL
faba-238	286	13	27.1	CARDINAL
faba-238	286	14	6	CARDINAL
faba-238	286	15	2	CARDINAL
faba-238	286	16	2024	CARDINAL
faba-238	286	17	227	CARDINAL
faba-238	286	18	13	CARDINAL
faba-238	287	1	first	ORDINAL
faba-238	288	1	14.00%	PERCENT
faba-238	288	2	19.11%	PERCENT
faba-238	288	3	12.00%	PERCENT
faba-238	288	4	4 700	CARDINAL
faba-238	288	5	12.44%	PERCENT
faba-238	288	6	19.02%	PERCENT
faba-238	288	7	37.86%	PERCENT
faba-238	288	8	202	CARDINAL
faba-238	288	9	110	CARDINAL
faba-238	288	10	9.31%	PERCENT
faba-238	288	11	14.59%	PERCENT
faba-238	288	12	38.78%	PERCENT
faba-238	288	13	75 260	CARDINAL
faba-238	288	14	merck & co.	ORG
faba-238	288	15	10.26%	PERCENT
faba-238	288	16	3.76%	PERCENT
faba-238	288	17	5.31%	PERCENT
faba-238	288	18	276 260	CARDINAL
faba-238	288	19	johnson	PERSON
faba-238	288	20	johnson 19.50%	ORG
faba-238	288	21	41.28%	PERCENT
faba-238	288	22	49.20%	PERCENT
faba-238	288	23	340	CARDINAL
faba-238	288	24	110	CARDINAL
faba-238	288	25	teva pharmaceutical industries	ORG
faba-238	288	26	19 260	CARDINAL
faba-238	288	27	14	CARDINAL
faba-238	289	1	second	ORDINAL
faba-238	290	1	14.00%	PERCENT
faba-238	290	2	19.11%	PERCENT
faba-238	290	3	12.00%	PERCENT
faba-238	290	4	4 700	CARDINAL
faba-238	290	5	teva pharmaceutical industries	ORG
faba-238	290	6	19 260	QUANTITY
faba-238	290	7	hikma pharmaceutical plc	ORG
faba-238	290	8	8.46%	PERCENT
faba-238	290	9	6.61%	PERCENT
faba-238	290	10	8.81%	PERCENT
faba-238	290	11	4 400	DATE
faba-238	290	12	sanofi s.a.	ORG
faba-238	291	1	4.30%	PERCENT
faba-238	291	2	11.60%	PERCENT
faba-238	291	3	7.30%	PERCENT
faba-238	291	4	118	CARDINAL
faba-238	291	5	bayer ag	ORG
faba-238	291	6	420	CARDINAL
faba-238	291	7	8.65%	PERCENT
faba-238	291	8	31.94%	PERCENT
faba-238	291	9	19.83%	PERCENT
faba-238	291	10	227	CARDINAL
faba-238	291	11	430	CARDINAL
faba-238	291	12	15	CARDINAL
faba-238	292	1	third	ORDINAL
faba-238	293	1	14.00%	PERCENT
faba-238	293	2	19.11%	PERCENT
faba-238	293	3	12.00%	PERCENT
faba-238	293	4	4 700	CARDINAL
faba-238	293	5	innoviva, inc	ORG
faba-238	293	6	7.46%	PERCENT
faba-238	293	7	33.30%	PERCENT
faba-238	293	8	16.24%	PERCENT
faba-238	293	9	1 030 faes farma	QUANTITY
faba-238	293	10	8.46%	PERCENT
faba-238	293	11	19.66%	PERCENT
faba-238	293	12	14.93%	PERCENT
faba-238	293	13	998	CARDINAL
faba-238	293	14	5.45%	PERCENT
faba-238	293	15	11.50%	PERCENT
faba-238	293	16	10.69%	PERCENT
faba-238	293	17	720	CARDINAL
faba-238	293	18	bavarian	NORP
faba-238	293	19	7.85%	PERCENT
faba-238	293	20	14.82%	PERCENT
faba-238	293	21	10.20%	PERCENT
faba-238	293	22	9.02%	PERCENT
faba-238	293	23	19.49 17.30%	PERCENT
faba-238	293	24	700	CARDINAL